Cogent Biosciences

Cogent Biosciences

Developing precision therapies for genetically defined diseases.

HQ location
Cambridge, United States
Launch date
Market cap
$809m
Enterprise value
$689m
Share price
$7.18 COGT
Authorizing premium user...